← Leaderboards
John R. Chan
Rutgers Biomedical And Health Sciences
$24,248,523
Attributed
$31,076,694
Total exposure
20
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,076,694 · 20
By mechanism
R01$22,896,846 · 8
P01$3,248,545 · 6
K12$1,883,928 · 1
R21$1,243,128 · 3
P30$1,201,678 · 1
KL2$602,569 · 1
Top collaborators
- Steven A Porcelli7 shared
- Jordi B Torrelles6 shared
- Ethan A Halm3 shared
- Padmini Salgame2 shared
- Rodrigo Ribeiro-Rodrigues1 shared
- Adrie Jc Steyn1 shared
Most similar at Rutgers Biomedical And Health Sciences
Same institution · by research overlap
- Abraham Pinter$23,454,706
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisInfectionDesignPlayResponsePathogenTuberculosis ImmunityAntitubercular AgentsImmunityImmune ResponseAnimalsAcuteMacrophageBaseProgramsCellsIn VivoGranulomaPhenotypeVaccinesChronicPersonsMouse Model
Grant awards (70)
NJ ACTS: A Platform for Translational Science in New Jersey: CTSA K12 Program at Rutgers, Biomedical Health Sciences$941,964
K12 · FY2025 · TR
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$830,828
R01 · FY2025 · AI · contact PI
B cells in the regulation of lung granulomatous inflammation in TB$781,369
R01 · FY2025 · AI · contact PI
Mechanisms of IFNg-independent T cell and B cell-mediated protection in TB.$769,589
R01 · FY2025 · AI
NJ ACTS: A Platform for Translational Science in New Jersey: CTSA K12 Program at Rutgers, Biomedical Health Sciences$941,964
K12 · FY2024 · TR
Mechanisms of IFNg-independent T cell and B cell-mediated protection in TB.$800,200
R01 · FY2024 · AI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$856,524
R01 · FY2023 · AI · contact PI
IgM in the regulation of TB immunity$736,298
R01 · FY2023 · AI · contact PI
Institutional Career Development Core$602,569
KL2 · FY2023 · TR
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$885,024
R01 · FY2022 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$783,413
R01 · FY2022 · AI · contact PI
IgM in the regulation of TB immunity$747,370
R01 · FY2022 · AI · contact PI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$135,414
R01 · FY2022 · AI · contact PI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$908,865
R01 · FY2021 · AI · contact PI
IgM in the regulation of TB immunity$685,810
R01 · FY2021 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$506,563
R01 · FY2021 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$299,905
R01 · FY2021 · AI · contact PI
IgM in the regulation of TB immunity$44,788
R01 · FY2021 · AI · contact PI
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis$926,013
R01 · FY2020 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$806,468
R01 · FY2020 · AI · contact PI
IgM in the regulation of TB immunity$727,759
R01 · FY2020 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$806,468
R01 · FY2019 · AI · contact PI
IgM in the regulation of TB immunity$700,549
R01 · FY2019 · AI · contact PI
Humoral immunity against the M. tuberculosis kasB persistent mutant$208,750
R21 · FY2019 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$503,978
R01 · FY2018 · AI · contact PI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis$302,490
R01 · FY2018 · AI · contact PI
Humoral immunity against the M. tuberculosis kasB persistent mutant$161,080
R21 · FY2018 · AI · contact PI
Humoral immunity against the M. tuberculosis kasB persistent mutant$89,420
R21 · FY2018 · AI · contact PI
B cells and humoral immunity in tuberculosis$520,331
R01 · FY2016 · AI · contact PI
B cells and humoral immunity in tuberculosis$414,289
R01 · FY2015 · AI · contact PI
"The Tuberculous Granuloma"$291,435
P01 · FY2015 · AI · contact PI
Animal Core$206,714
P01 · FY2015 · AI · contact PI
B cells and humoral immunity in tuberculosis$138,096
R01 · FY2015 · AI · contact PI
"The Tuberculous Granuloma"$116,671
P01 · FY2015 · AI · contact PI
"The Tuberculous Granuloma"$58,286
P01 · FY2015 · AI · contact PI
Animal Core$41,342
P01 · FY2015 · AI · contact PI
"The Tuberculous Granuloma"$23,335
P01 · FY2015 · AI · contact PI
B cells and humoral immunity in tuberculosis$703,554
R01 · FY2014 · AI · contact PI
"The Tuberculous Granuloma"$349,720
P01 · FY2014 · AI · contact PI
Animal Core$248,057
P01 · FY2014 · AI · contact PI
"The Tuberculous Granuloma"$129,111
P01 · FY2014 · AI · contact PI
B cells and humoral immunity in tuberculosis$661,340
R01 · FY2013 · AI · contact PI
"The Tuberculous Granuloma"$344,276
P01 · FY2013 · AI · contact PI
Animal Core$220,983
P01 · FY2013 · AI · contact PI
Animal Biohazard Core$95,494
P30 · FY2013 · AI · contact PI
B cells and humoral immunity in tuberculosis$729,368
R01 · FY2012 · AI · contact PI
"The Tuberculous Granuloma"$379,664
P01 · FY2012 · AI · contact PI
Animal Core$234,726
P01 · FY2012 · AI · contact PI
Animal Biohazard Core$195,096
P30 · FY2012 · AI · contact PI
Cell Migration in Tuberculosis Infection$386,711
R01 · FY2011 · HL · contact PI
"The Tuberculous Granuloma"$345,859
P01 · FY2011 · AI · contact PI
Animal Biohazard Core$264,497
P30 · FY2011 · AI · contact PI
Animal Core$258,366
P01 · FY2011 · AI · contact PI
Cell Migration in Tuberculosis Infection$386,898
R01 · FY2010 · HL · contact PI
Animal Biohazard Core$192,953
P30 · FY2010 · AI · contact PI
Cell Migration in Tuberculosis Infection$387,079
R01 · FY2009 · HL · contact PI
Animal Biohazard Core$217,663
P30 · FY2009 · AI · contact PI
Cell Migration in Tuberculosis Infection$387,256
R01 · FY2008 · HL · contact PI
Animal Biohazard Core$235,975
P30 · FY2008 · AI · contact PI
Cell Migration in Tuberculosis Infection$403,926
R01 · FY2007 · HL · contact PI
Cell Migration in Tuberculosis Infection$605,986
R01 · FY2006 · HL · contact PI
Cell Migration in Tuberculosis Infection$604,044
R01 · FY2005 · HL
Cell Migration in Tuberculosis Infection$537,909
R01 · FY2004 · HL
Cell Migration in Tuberculosis Infection$50,100
R01 · FY2004 · HL
Cell Migration in Tuberculosis Infection$522,759
R01 · FY2003 · HL
M tuberculosis truncated hemoglobins in persistence$206,950
R21 · FY2003 · AI
Cell Migration in Tuberculosis Infection$524,788
R01 · FY2002 · HL
M tuberculosis truncated hemoglobins in persistence$223,700
R21 · FY2002 · AI
TNF-alpha in Tuberculosis$353,228
R21 · FY2001 · AI
IMMUNE MECHANISMS OF REACTIVATION OF TUBERCULOSIS$386,727
R01 · FY2000 · AI